Navigation Links
Bud Owen and Tony Click Join Clinverse, Inc. as Chief Financial Officer and Chief Technology Officer
Date:7/31/2013

Raleigh, NC (PRWEB) July 31, 2013

Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today the addition of Bud Owen as Chief Financial Officer and Tony Click as Chief Technology Officer. Both Bud and Tony bring extensive experience in their respective fields and serve as strategic members of the management team for the company.

In his role as CFO, Bud leads all financial aspects of the company, including accounting, treasury, tax and human resources activities. He is a veteran senior finance executive who was most recently with Clinipace, Inc., a global CRO. Prior to Clinipace, Bud served as CFO at a number of global companies in the software, web services, media and chemical industries. During his career, he has been either a principal or an advisor in more than 40 M&A transactions with a total transaction value of $1.5 billion. Bud has a Master of Business Administration from Queens University (Canada) and is an Ernst & Young (Toronto) alumni.

As Chief Technology Officer, Tony is responsible for all technical and architectural aspects of Clinverse’s software and eclinical commerce network. He brings more than 20 years of experience developing customer software solutions across many industries including finance, insurance, publishing, telecom, construction and utilities. His specialties include systems with high throughput, computationally intensive and ‘Big Data’ requirements. Prior to joining Clinverse, Tony provided outsourced CTO services for early-stage startups and served as the VP of Enterprise Architecture at Merkle, a database analytics company. Tony also ran his own consulting firm for 11 years, which delivered architectural and project management services. He received a Bachelor of Science in Electrical Engineering from Virginia Tech and a Master of Business Administration from Duke University’s Fuqua School of Business.

"We look forward to leveraging Bud and Tony’s industry knowledge and expertise to continue to grow our lead in the area of financial lifecycle systems for the clinical trials industry," said Steve Ayala, Clinverse co-founder and president. "Their leadership and experience are critical to our success as we continue to expand globally and seek to provide our customers with exceptional financial process automation solutions that fill an important, yet unmet need in clinical trials."

About Clinverse, Inc.

Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay®, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit http://www.clinverse.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10973719.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
2. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
3. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
4. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
5. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
6. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
7. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
8. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
9. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
10. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
11. Codexis Names Wes Bolsen VP and Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , ... a developer of innovative sensor-based diagnostic products, today announced the ... by new and existing investors.  Proceeds from the financing will ... Scanner , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The ...
Breaking Biology News(10 mins):